Sign In
Last checked at 
23 Sep 2025 16:00
Primary Health Properties PLC
Director's & PDMR dealings
On 25 February 2025, the remuneration committee of Primary Health Properties PLC (the "Company" or "PHP") approved the following awards of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to Directors and Persons Discharging Managerial Responsibilities ("PDMR's"). These awards, deferred because the Company was subsequently in a prolonged closed period, have now been made on 23 September 2025.
Director | Number of shares under option |
Mark Davies | 969,643 |
Richard Howell | 670,438 |
PDMR | |
David Austin | 137,224 |
Toby Newman | 120,421 |
The number of nil-cost options were calculated by reference to a price of £0.8927, being the average of the closing middle market quotations for the Company's ordinary shares on 17, 18 and 19 September 2025.
The nil-cost options will vest subject to the attainment of performance conditions measured over three years to 31 December 2027. The remuneration committee has the discretion to adjust the awards downwards at vesting for malus reasons. Details of the operation of the LTIP are set out in the Company's 2023 Report and Accounts.
Details of the transactions referenced above are included below in accordance with the under Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
(a) | Name | Mark Davies
| |
2 | Reason for notification | ||
(a) | Position/Status | Chief Executive Officer | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 969,643
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 23 September 2025 | |
(f) | Place of transaction | N/A
| |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
(a) | Name | Richard Howell
| |
2 | Reason for notification | ||
(a) | Position/Status | Chief Financial Officer | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 670,438
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 23 September 2025
| |
(f) | Place of transaction | N/A
| |
1 | Details of the person discharging managerial responsibility/person closely associated | ||
(a) | Name | David Austin
| |
2 | Reason for notification | ||
(a) | Position/Status | PDMR | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 137,224
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 23 September 2025
| |
(f) | Place of transaction | N/A
| |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
(a) | Name | Toby Newman
| |
2 | Reason for notification | ||
(a) | Position/Status | Company Secretary & Chief Legal Officer | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 120,421
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 23 September 2025
| |
(f) | Place of transaction | N/A
| |
More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk
Further details:
Mark Davies Chief Executive Officer
| via Burson Buchanan
Tel: +44 (0) 20 7466 5066 |
Richard Howell Chief Financial Officer
| via Burson Buchanan Tel: +44 (0) 20 7466 5066 |
Stephanie Whitmore (Burson Buchanan) Tel: +44 (0) 20 7466 5066 |
Legal Entity Identifier: 213800Y5CJHXOATK7X11
Follow the stocks
